INTEGRA LIFESCIENCES HOLDING (IART) Stock Price & Overview
NASDAQ:IART • US4579852082
Current stock price
The current stock price of IART is 10.75 USD. Today IART is up by 2.19%. In the past month the price increased by 12.68%. In the past year, price decreased by -36.05%.
IART Key Statistics
- Market Cap
- 836.673M
- P/E
- 4.82
- Fwd P/E
- 4.49
- EPS (TTM)
- 2.23
- Dividend Yield
- N/A
IART Stock Performance
IART Stock Chart
IART Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to IART. When comparing the yearly performance of all stocks, IART is a bad performer in the overall market: 87.48% of all stocks are doing better.
IART Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to IART. IART may be in some trouble as it scores bad on both profitability and health.
IART Earnings
On February 26, 2026 IART reported an EPS of 0.83 and a revenue of 434.93M. The company beat EPS expectations (1.67% surprise) and missed revenue expectations (-0.75% surprise).
IART Forecast & Estimates
16 analysts have analysed IART and the average price target is 16.66 USD. This implies a price increase of 54.98% is expected in the next year compared to the current price of 10.75.
For the next year, analysts expect an EPS growth of 7.41% and a revenue growth 2.65% for IART
IART Groups
Sector & Classification
IART Financial Highlights
Over the last trailing twelve months IART reported a non-GAAP Earnings per Share(EPS) of 2.23. The EPS decreased by -12.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -14.34% | ||
| ROE | -49.5% | ||
| Debt/Equity | 1.66 |
IART Ownership
IART Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 41.46 | 171.767B | ||
| ABT | ABBOTT LABORATORIES | 14.59 | 159.344B | ||
| SYK | STRYKER CORP | 21.78 | 126.134B | ||
| BSX | BOSTON SCIENTIFIC CORP | 16.43 | 96.409B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.06 | 47.005B | ||
| IDXX | IDEXX LABORATORIES INC | 39.06 | 45.933B | ||
| BDX | BECTON DICKINSON AND CO | 11.4 | 44.32B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.81 | 32.57B | ||
| RMD | RESMED INC | 18.08 | 32.347B | ||
| DXCM | DEXCOM INC | 24.93 | 24.404B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.97 | 18.01B | ||
| PODD | INSULET CORP | 29.86 | 13.41B | ||
| PEN | PENUMBRA INC | 65.18 | 13.063B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About IART
Company Profile
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,427 full-time employees. The firm manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
Company Info
IPO: 1995-08-16
INTEGRA LIFESCIENCES HOLDING
1100 Campus Road
Princeton NEW JERSEY 08540 US
CEO: Peter J. Arduini
Employees: 4427
Phone: 16092750500
INTEGRA LIFESCIENCES HOLDING / IART FAQ
Can you describe the business of INTEGRA LIFESCIENCES HOLDING?
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,427 full-time employees. The firm manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
What is the current price of IART stock?
The current stock price of IART is 10.75 USD. The price increased by 2.19% in the last trading session.
What is the dividend status of INTEGRA LIFESCIENCES HOLDING?
IART does not pay a dividend.
What is the ChartMill technical and fundamental rating of IART stock?
IART has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is INTEGRA LIFESCIENCES HOLDING (IART) stock traded?
IART stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of INTEGRA LIFESCIENCES HOLDING (IART)?
The PE ratio for INTEGRA LIFESCIENCES HOLDING (IART) is 4.82. This is based on the reported non-GAAP earnings per share of 2.23 and the current share price of 10.75 USD.
What is the employee count for IART stock?
INTEGRA LIFESCIENCES HOLDING (IART) currently has 4427 employees.